Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

LOPINAVIR AND RITONAVIR

LOPINAVIR;RITONAVIR

Standard Dose
40MG;10MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: None (Tentative Approval)
Summary

Approval overview LOPINAVIR AND RITONAVIR is listed in Drugs@FDA under application 205425 (NDA).

Review priority: PRIORITY Marketing status: None (Tentative Approval) Active ingredient LOPINAVIR;RITONAVIR Form and strength PELLETS;ORAL - 40MG;10MG Sponsor CIPLA LTD Submission history Latest submission status date: 2015-05-21 00:00:00.

Structured Monograph

Clinical summary

Approval overview LOPINAVIR AND RITONAVIR is listed in Drugs@FDA under application 205425 (NDA). Review priority: PRIORITY Marketing status: None (Tentative Approval) Active ingredient LOPINAVIR;RITONAVIR Form and strength PELLETS;ORAL - 40MG;10MG Sponsor CIPLA LTD Submission history Latest submission status date: 2015-05-21 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: None (Tentative Approval)
  • • Review priority: PRIORITY

Interaction Notes

  • No interaction notes stored yet.